Products & Services · Loss contingency accrual

JAKAFI — Loss contingency accrual

Incyte JAKAFI — Loss contingency accrual increased by 12.5% to $245.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 69.1%, from $145.40M to $245.90M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2023
Last reportedQ1 2026Apr 28, 2026

How to read this metric

An increase suggests rising legal or operational risks, while a decrease indicates a resolution of disputes or reduced risk exposure.

Detailed definition

This metric represents the amount reserved on the balance sheet to cover potential future losses related to legal or con...

Peer comparison

Common in pharmaceutical companies facing litigation or regulatory scrutiny.

Metric ID: incy_segment_jakafi_loss_contingency_accrual

Historical Data

11 periods
 Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$42.90M$59.50M$73.70M$91.10M$106.90M$127.60M$145.40M$165.20M$188.90M$218.50M$245.90M
QoQ Change+38.7%+23.9%+23.6%+17.3%+19.4%+13.9%+13.6%+14.3%+15.7%+12.5%
YoY Change+149.2%+114.5%+97.3%+81.3%+76.7%+71.2%+69.1%
Range$42.90M$245.90M
CAGR+101.1%
Avg YoY Growth+94.2%
Median YoY Growth+81.3%
Current Streak10+ quarters growth

Frequently Asked Questions

What is Incyte's jakafi — loss contingency accrual?
Incyte (INCY) reported jakafi — loss contingency accrual of $245.90M in Q1 2026.
How has Incyte's jakafi — loss contingency accrual changed year-over-year?
Incyte's jakafi — loss contingency accrual increased by 69.1% year-over-year, from $145.40M to $245.90M.
What does jakafi — loss contingency accrual mean?
The financial reserve set aside for potential legal or contractual losses.